Dr. Ben Frisch's Innovative Leukemia Research at University of Rochester
Dr. Ben Frisch, a dedicated researcher, is making waves in the field of leukemia research at the University of Rochester. Despite limited public information about his background and the hospital he's affiliated with, Frisch's work is undeniably impactful.
Frisch's journey in research is deeply rooted in his upbringing on a dairy farm in Nunda, NY. Rising at 5 a.m. daily to feed cows instilled in him a strong work ethic that translates into his 24/7 approach to science, much like farming.
Currently, Frisch is an assistant professor of Pathology and Laboratory Medicine and Biomedical Engineering. His current project involves building a microchip model of the human bone marrow, a significant step forward in leukemia research. This innovative work is a testament to Frisch's focus on bench science applicable to leukemia and other blood diseases.
Frisch's expertise has been honed through groundbreaking work on blood cells in prominent labs at the University of Rochester. His insights into how leukemia impacts the bone marrow and leads to malignancy are invaluable. Notably, he is part of a trio designing a unique drug-delivery system for cancer, further cementing his status as an independent investigator.
Dr. Ben Frisch's dedication to his work, fueled by his rural upbringing and passion for understanding leukemia's impact on the bone marrow, is driving innovative research at the University of Rochester. His contributions to leukemia research, including the microchip model of human bone marrow and the unique drug-delivery system, highlight his commitment to advancing the field.
